Track Biotech Catalysts in One Place

A biotech catalyst calendar is a way to track upcoming FDA dates, clinical readouts, and company events that can change how a biotech stock trades.

An FDA calendar is a dated view of upcoming regulatory milestones such as PDUFA dates, advisory committee meetings, and other decision points tied to biotech companies.

A PDUFA date is the target date by which the FDA aims to decide on a drug application, making it one of the most important biotech catalyst dates to watch.

A biotech watchlist is a saved set of companies, drugs, or keywords you want to keep visible so you can follow the same names and catalysts over time.

Biotech alerts work by monitoring the sources you care about and surfacing new catalyst-style headlines as they arrive, so you can react without manually checking many pages.

BioPharmSignal is designed to surface critical biotech headlines within minutes whenever possible, especially for company press releases, FDA updates, SEC filings, and clinical trial news.

No. Coverage is automatic across the U.S.-listed biotech and pharma universe, so you can start with the livefeed and then narrow the view using saved tickers and keywords when needed.

BioPharmSignal focuses on high-signal official and near-official sources, including company press releases, SEC filings, FDA updates, and clinical trial headlines that can move biotech stocks.

The product is built for biotech investors, operators, and teams that need fast awareness of catalyst-driven updates without monitoring dozens of investor relations pages manually.

Yes. BioPharmSignal supports saved tickers and keywords so you can focus on a small watchlist, a handful of catalysts, or a broader theme such as obesity, oncology, or gene editing.

Typical events include FDA decisions, PDUFA-related headlines, clinical readouts, partnership announcements, financing news, SEC filings, launch updates, and other catalyst-style company news.